Recent Company News

• 02:40 AM ET Aug 04, 2025
  

  Hisamitsu Pharmaceutical initiates phase III clinical trial of HP-6050 in Japan (¥4109.0000, 0)

• 02:51 AM ET Jul 10, 2025
  

  Hisamitsu Pharmaceutical signs agreement with Toyo Pharmaceutical Kasei for TH-004; launches ¥15B share buyback, to run until 31-Dec (¥4027.0000, 0)

• 02:37 AM ET Jul 10, 2025
  

  Hisamitsu Pharmaceutical reports Q1 net income attributable ¥2.56B, (46%) vs year-ago ¥4.79B (¥4027.0000, 0)

• 11:05 PM ET Apr 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:39 AM ET Apr 10, 2025
  

  Hisamitsu Pharmaceutical reports Q4 net income attributable ¥8.10B vs year-ago ¥1.88B (¥3984.0000, 0)

• 10:37 PM ET Jan 13, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (106 total)

• 10:14 PM ET Jan 13, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (65 total)

• 10:46 PM ET Jan 09, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (142 total)

• 10:10 PM ET Jan 09, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:07 PM ET Jan 09, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (46 total)